Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.
about
Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphomaComments on the mechanisms of action of radiation protective agents: basis components and their polyvalenceAging and cancer: issues of basic and clinical science.Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia.Granulocyte colony-stimulating factor use in cancer patients.Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia.Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study.Febrile neutropenia in hematologic malignancies.Economic evaluations of granulocyte colony-stimulating factor: in the prevention and treatment of chemotherapy-induced neutropenia.Attitudes and practice patterns for maintaining relative dose intensity of chemotherapy in outpatient clinics: results of a Japanese web-based survey.Prediction of docetaxel monotherapy-induced neutropenia based on the monocyte percentage.A way forward on the medically appropriate use of white cell growth factorsRetinoid agonist Am80-enhanced neutrophil bactericidal activity arising from granulopoiesis in vitro and in a neutropenic mouse model.Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohortAm80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortality.Use of colony-stimulating factor in patients with ovarian cancer receiving paclitaxel and carboplatin in Japan.Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumors.Granulocyte colony-stimulating factor receptor mutations in myeloid malignancy.Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia.Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models.Mirimostim (macrophage colony-stimulating factor; M-CSF) improves chemotherapy-induced impaired natural killer cell activity, Th1/Th2 balance, and granulocyte function.Macrophage colony-stimulating factor prevents febrile neutropenia induced by chemotherapy.Increased myeloperoxidase index and large unstained cell values can predict the neutropenia phase of cancer patients treated with standard dose chemotherapy.Filgrastim (G-CSF) loaded liposomes: mathematical modeling and optimization of encapsulation efficiency and particle sizePolysaccharides isolated from Echinacea purpurea herba cell cultures to counteract undesired effects of chemotherapy--a pilot study.Filgrastim-mediated neutrophil recovery in patients with breast cancer treated with docetaxel and doxorubicin.Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer.Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy.Evaluation of infection control advice for patients at risk of chemotherapy-induced neutropenia in 2 pediatric oncology centers: Cape Town, South Africa, and Newcastle-Upon-Tyne, UK.Hematopoietic effect of fractions from the enzyme-digested colla corii asini on mice with 5-fluorouracil induced anemia.Neutrophils in critical illness.Adequate Neutrophil Responses and Non-Inferior Clinical Outcomes Can Be Achieved by a Two-Day Course of Low-Dose Filgrastim: A Retrospective Single Institution Experience.Radiation mitigation effect of cultured mushroom fungus Hirsutella Sinensis (CorImmune) isolated from a Chinese/Tibetan herbal preparation -Cordyceps Sinensis.Macrophage colony-stimulating factor (M-CSF) prevents infectious death induced by chemotherapy in mice, while granulocyte-CSF does not.The timing of granulocyte-colony-stimulating factor administration after chemotherapy does not affect stem and progenitor cell apheresis yield: a retrospective study of 65 casesThe dose of granulocyte-colony-stimulating factor after chemopriming treatment does not influence apheresis yield of progenitor cells: a retrospective study of 91 cases
P2860
Q24240753-B3ADBDE2-0A53-433C-AE0E-BD3FC670D2DAQ27004405-C107EFA2-1B7B-487B-B175-447C8968F8D3Q30492440-FE74BEBF-4AA0-4F54-A3D2-47DA67852CC8Q33390157-13F177CD-AC9B-47FA-98AC-398EEC4D1E1AQ33992518-C03A1CEB-779D-4452-8906-96A76539AE7CQ34436603-AFA1DD94-60C8-497C-B302-400E7F3CF941Q34521035-F37B43FF-FAD7-4075-B6BC-14991FD6BB69Q34655730-05441627-15BD-4D25-870D-FB0889CAE454Q35642536-C3AAF85E-B67D-458F-9476-6452D544089EQ35799944-D8373174-2560-4463-8E61-21F521A37BF6Q35995548-79BABEDC-E04A-4250-BE4F-358D00553F23Q36058245-4A6A7D11-3341-48C0-AB24-1835DA8981D6Q36595328-3DF75217-AA2F-400F-BC24-7BD648D39615Q36949179-1AE5D3AC-B0CD-4FA9-A580-B5D684009EE4Q37387000-25F2ECBC-F85F-4A75-8048-4DBC5882FDEDQ37717738-F8406753-43C5-416B-8860-923C7AA92D96Q37931905-0EDB7094-E0B2-4B5C-86B8-75D0FE9345BBQ38211431-8C49F83B-EA6D-4518-9502-4C44A4317596Q38225700-82E683C0-03C2-4F70-8740-672DD4AEF29AQ38256944-6A97CB5B-E95E-4956-A73E-B5B142B02FA1Q40340358-F7C2CE7B-B0B5-4256-AA1F-18D67D4AF5A2Q40550711-26D4EE22-272A-449B-81E1-D4EEE23B1F65Q40593186-FB475D8F-F814-4888-B625-F5E063090C2EQ40604275-4916B2A1-1128-4E10-9EC5-E49A06539353Q41850304-9F9A5BED-2FF3-40EE-B8D8-3AA34CC735ADQ43947551-BA80E19D-74BD-4B5C-8B79-F721E0817126Q44657173-9B4EC6A8-61DE-4C9B-828B-92ADC91E26D2Q45847822-8B44517B-5FBF-4E78-88B0-2DB07A00A652Q46385900-C2BED58B-4ED1-4FC2-BE5B-DA2BF7CC40E7Q46887857-9DE44B4E-629C-4091-8CEB-AF43F2D2D152Q46929554-07CE0C92-5C9B-4800-A470-F6761ECA0AB0Q49788597-E474D5C6-96A9-44F9-9175-A0908CC043F7Q50318146-A3A269A2-8976-4554-972A-27CC765EE0B6Q53500578-3EEC7F07-9246-4ABA-BE7A-EC072A1D19B3Q55383761-CAFB7A86-DC3A-437C-B0A1-BA1EDD13BF11Q57218922-DC0F020D-1E66-41E5-B080-1FA15E0D7A50Q57218967-E2DB509B-0A77-4A33-8E6E-E777E1492612
P2860
Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Granulocyte colony-stimulating ...... -induced afebrile neutropenia.
@en
type
label
Granulocyte colony-stimulating ...... -induced afebrile neutropenia.
@en
prefLabel
Granulocyte colony-stimulating ...... -induced afebrile neutropenia.
@en
P2093
P1476
Granulocyte colony-stimulating ...... -induced afebrile neutropenia.
@en
P2093
Habermann TM
Hartmann LC
Johnson PS
Mailliard JA
Moertel CG
Tschetter LK
P304
P356
10.1056/NEJM199706193362502
P407
P577
1997-06-01T00:00:00Z